Categories
Health

Novel Monoclonal Antibody Shows Promise in Ulcerative Colitis

Source link : https://www.newshealth.biz/health-news/novel-monoclonal-antibody-shows-promise-in-ulcerative-colitis/

Significantly more patients with moderately to severely active ulcerative colitis achieved clinical remission with the investigational monoclonal antibody tulisokibart compared with placebo, a randomized phase II trial showed. Among 135 adults, 26% achieved clinical remission at 12 weeks with tulisokibart compared with 1% of those receiving placebo (P

Author : News Health

Publish date : 2024-09-25 21:00:00

Copyright for syndicated content belongs to the linked Source.

..........................%%%...*...........................................$$$$$$$$$$$$$$$$$$$$--------------------.....